Wu Wei-Zhong, Sun Hui-Chuan, Shen Yue-Fang, Chen Jie, Wang Lu, Tang Zhao-You, Iliakis George, Liu Kang-Da
Liver Cancer Institute and Zhongshan Hospital, Fudan University, 136 Yi Xue Yuan Road, 200032 Shanghai, P.R.China.
J Cancer Res Clin Oncol. 2005 Mar;131(3):169-78. doi: 10.1007/s00432-004-0615-2. Epub 2004 Dec 11.
An earlier report demonstrated that interferon alpha (IFN-alpha) inhibited tumor growth and recurrence in an MHCC97 xenograft model in nude mice by suppressing tumor angiogenesis rather than by inhibiting tumor cell proliferation. However, the underlying molecular mechanism was not fully elucidated. In this study, we demonstrated that IFN-alpha 2a could down-regulate VEGF expression both in mRNA and in protein levels, as well as down-regulating HIF-1 alpha mRNA expression in MHCC97 cells in vitro. A cDNA micro array analysis followed by Northern and Western blot analysis revealed that PI3 kinase and MAP kinase signaling pathways might be inhibited by IFN-alpha 2a. Blocking the function of IFN-alpha receptor with a specific peptide could eliminate the inhibitory effects of IFN-alpha 2a on VEGF expression. In addition, wortmannin and PD098059, respective inhibitors of the PI3 kinase and the MAP kinase signaling pathways, when used independently or in combination, could also down-regulate the VEGF synthesis and secretion in a similar pattern of IFN-alpha 2a. These observations may lead to the conclusion that IFN-alpha 2a could suppress VEGF synthesis and secretion by down-regulating HIF-1 alpha expression, via inhibition of the PI3 kinase and/or the MAP kinase signaling pathways.
较早的一份报告表明,α干扰素(IFN-α)通过抑制肿瘤血管生成而非抑制肿瘤细胞增殖,抑制了裸鼠MHCC97异种移植模型中的肿瘤生长和复发。然而,其潜在的分子机制尚未完全阐明。在本研究中,我们证明IFN-α 2a在体外可下调MHCC97细胞中VEGF的mRNA和蛋白水平表达,以及下调HIF-1α mRNA表达。随后进行的cDNA微阵列分析以及Northern和Western印迹分析显示,PI3激酶和MAP激酶信号通路可能受到IFN-α 2a的抑制。用特异性肽阻断IFN-α受体的功能可消除IFN-α 2a对VEGF表达的抑制作用。此外,PI3激酶和MAP激酶信号通路的各自抑制剂渥曼青霉素和PD098059单独使用或联合使用时,也能以与IFN-α 2a类似的模式下调VEGF的合成和分泌。这些观察结果可能得出结论,IFN-α 2a可通过抑制PI3激酶和/或MAP激酶信号通路,下调HIF-1α表达,从而抑制VEGF的合成和分泌。